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Introduction
Advances in palliation of congenital heart disease have
resulted in improved survival to adulthood. Nevertheless
many of these patients ultimately develop end-stage heart
failure requiring heart transplantation. Implantation of
ventricular assist device is life-saving option for such
patients, allowing for bridge to transplant. In the present
study we describe our experience with implantation of
ventricular assist device Heart Mate II as bridge to trans-
plant in adult patients with congenital heart disease.
Methods
Of 104 patients who underwent ventricular assist device
implantation at our institute from December 2007 to
April 2013, 8 patients ranging in age from 14 to 40
years (6 male), in the end-stage of the heart failure were
diagnosed to have adult congenital heart disease. We
retrospectively reviewed the clinical data, operative and
postoperative courses of these patients.
Results
Anatomical diagnoses were transposition of the great
arteries in 6 patients (5 patients have Mustard procedure
as a child and one patient has congenitally corrected
transposition of the great arteries), single-ventricle defect
in 1 patient and coarctation of aorta in 1 patient.
Despite high risk heart surgery, implantation of ventri-
cular assist device was performed in all patients with
zero perioperative mortality. Overall mechanical support
time was 232 ± 116 days (mean ± SD; range 34 - 349
days). Four patients were successfully bridged to heart
transplantation, three patients unfortunately suffered
from thromboembolic and septic complications and had
died, and one is still waiting for heart transplant.
Conclusion
Adults with congenital heart defects and congestive heart
failure are a challenging population because of their com-
plex anatomy, prior surgical palliation, and hemodynamic
status. We conclude from our experience that ventricular
assist device surgery can be safely performed in these high
risk patients.
Study was supported by Grant IGA MZ NT/11269–5.
Authors’ details
1Department of Cardiac Surgery, Institute for Clinical and Experimental
Medicine, Prague, Czech Republic. 2Department of Cardiac Anaesthesiology,
Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
3Department of Cardiology, Institute for Clinical and Experimental Medicine,
Prague, Czech Republic.
Published: 11 September 2013
doi:10.1186/1749-8090-8-S1-O65
Cite this article as: Szárszoi et al.: Ventricular assist device implantation
in grown-up congenital heart disease patients. Journal of Cardiothoracic
Surgery 2013 8(Suppl 1):O65.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: onsz@ikem.cz
1Department of Cardiac Surgery, Institute for Clinical and Experimental
Medicine, Prague, Czech Republic
Full list of author information is available at the end of the article
Szárszoi et al. Journal of Cardiothoracic Surgery 2013, 8(Suppl 1):O65
http://www.cardiothoracicsurgery.org/content/8/S1/O65
© 2013 Szárszoi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
